Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Saxenhofer

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Therapeutische Umschau. Revue Therapeutique|June 1, 1990
[HMG-CoA-reductase inhibitors: a new principle in the treatment of hypercholesterolemia]H Saxenhofer, P Weidmann
Zeitschrift Fur Kardiologie|January 1, 1988
[Pharmacologic effects of atrial natriuretic peptide in humans]H Saxenhofer, P Weidmann
Schweizerische Medizinische Wochenschrift|December 5, 1987
[History and physiology of atrial natriuretic peptides in man]P Weidmann, H Saxenhofer, C Ferrier
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|September 27, 1994
[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study]P Erne, H Saxenhofer, B Waeber, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1994
Use of drugs with more than a twenty-four-hour duration of actionB Waeber, P Erne, H Saxenhofer, et al.
The American Journal of Physiology|February 1, 1993
Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cellsH Saxenhofer, W R Fitzgibbon, R V Paul
Journal of Steroid Biochemistry|January 1, 1989
Atrial natriuretic peptide in manP Weidmann, H Saxenhofer, S G Shaw, et al.
Acta Endocrinologica|June 1, 1988
Corticosteroid-induced stimulation of atrial natriuretic peptide in manH Saxenhofer, M Angst, P Weidmann, et al.
The American Journal of Physiology|January 1, 1996
Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclaseR V Paul, H Saxenhofer, P S Wackym, et al.
Clinical Nephrology|October 1, 1992
Impact of dialysis modality on body composition in patients with end-stage renal diseaseH Saxenhofer, J Scheidegger, C Descoeudres, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Therapeutische Umschau. Revue Therapeutique|June 1, 1990
[HMG-CoA-reductase inhibitors: a new principle in the treatment of hypercholesterolemia]H Saxenhofer, P Weidmann
Zeitschrift Fur Kardiologie|January 1, 1988
[Pharmacologic effects of atrial natriuretic peptide in humans]H Saxenhofer, P Weidmann
Schweizerische Medizinische Wochenschrift|December 5, 1987
[History and physiology of atrial natriuretic peptides in man]P Weidmann, H Saxenhofer, C Ferrier
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|September 27, 1994
[Time of drug intake in hypertension and angina pectoris. A controlled monitoring study]P Erne, H Saxenhofer, B Waeber, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|November 1, 1994
Use of drugs with more than a twenty-four-hour duration of actionB Waeber, P Erne, H Saxenhofer, et al.
The American Journal of Physiology|February 1, 1993
Urodilatin: binding properties and stimulation of cGMP generation in rat kidney cellsH Saxenhofer, W R Fitzgibbon, R V Paul
Journal of Steroid Biochemistry|January 1, 1989
Atrial natriuretic peptide in manP Weidmann, H Saxenhofer, S G Shaw, et al.
Acta Endocrinologica|June 1, 1988
Corticosteroid-induced stimulation of atrial natriuretic peptide in manH Saxenhofer, M Angst, P Weidmann, et al.
The American Journal of Physiology|January 1, 1996
Stimulation of rat mesangial cell thromboxane A2 receptors inhibits particulate but not soluble guanylyl cyclaseR V Paul, H Saxenhofer, P S Wackym, et al.
Clinical Nephrology|October 1, 1992
Impact of dialysis modality on body composition in patients with end-stage renal diseaseH Saxenhofer, J Scheidegger, C Descoeudres, et al.
Pageof 3